Connecting Molecules to Medicine
A special commitment to innovation
Through our deeply ingrained commitment to innovative R&D, Nexus Pharmaceuticals identifies those off-patent and unique molecules that can be developed, improved upon and commercialized so as to advance industry standards and deliver on the critical medical need.
We seek out difficult-to-formulate molecules with significant medical need
We innovate and improve the formulations to advance industry practice
We maintain the highest standards to deliver FDA-approved, life-saving drugs
A special attention to quality
Through our partnerships with leading US-based industry suppliers and manufacturers, privately owned Nexus Pharmaceuticals can ensure consistent, dependable access to the highest-quality products. Our steadfast record of delivery ensures that our critical-need drugs are always available when and where they’re needed most.
About Us
News
Nexus Pharmaceuticals Announces FDA Approval of Dicyclomine HCl Injection, USPNexus Pharmaceuticals announced today it has received U.S. Food and Drug Administration (FDA) approval for Dicyclomine Hydrochloride (HCl) Injection, USP in 20mg/2mL vial, the generic equivalent to Bentyl®... Read More
Nexus Pharmaceuticals Announces FDA Approval of Busulfan Injection
Nexus Pharmaceuticals Inc. announced today the U.S. Food and Drug Administration (FDA) approval of Busulfan Injection, the company's AP-rated therapeutic equivalent for Busulfex®... Read More See More News
® 2018 Nexus Pharmaceuticals, Inc.